Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT00690482 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe COPD

Interventions

DRUG: AZD1981
DRUG: Placebo

Sponsor

AstraZeneca